Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial

Maltais, F; Bjermer, L; Kerwin, EM; Jones, PW; Watkins, ML; Tombs, L; Naya, IP; Boucot, IH; Lipson, DA; Compton, C; Vahdati-Bolouri, M; Vogelmeier, CF

Maltais, F (reprint author), Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Pneumol, Quebec City, PQ, Canada.

RESPIRATORY RESEARCH, 2019; 20 (1):

Abstract

Background: Prospective evidence is lacking regarding incremental benefits of long-acting dual-versus monobronchodilation in improving symptoms and pr......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索